Astonea Labs Ltd
₹323.00▼ -1.00 (-0.31%)
ASTONEALAB·BSE·Healthcare
Market Cap
339.51 Cr
PE Ratio
71.94
Volume
1,000
Day High - Low
323.00 - 323.00
52W High-Low
369.00 - 118.00
₹323.00▼ -1.00 (-0.31%)
Market Cap339.51 Cr
PE Ratio71.94
Volume1,000
Day High - Low323.00 - 323.00
52W High-Low369.00 - 118.00
Astonea Labs Ltd (ASTONEALAB): company summary
The company's business has grown significantly, with annual revenue rising 51.0% year-over-year.
Astonea Labs Ltd (ASTONEALAB) is a micro-cap Healthcare company valued at ₹340 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Astonea Labs Ltd last traded at ₹323, modestly down 0.31% on the day.
- Recent developments
- On 2026-03-31, the company reported its latest financial results, showing revenue of ₹81 crore and net profit of ₹3 crore. The company has not paid dividends despite repeated profits, and working capital days increased to 74.2 days from 41.3 days.
- Financial performance
- The company's business has grown significantly, with annual revenue rising 51.0% year-over-year. However, net profit remained flat at ₹5 crore, and the net profit margin declined 1.7 percentage points to 3.4%. The latest quarter saw revenue of ₹81 crore, up from ₹66 crore in the prior year quarter, but net profit fell to ₹3 crore from ₹1 crore.
- Valuation multiples
- The stock trades at 71.9 times earnings, a premium to the Healthcare median of 32.0, 6.35 times book value.
- Things to watch
- The company's net profit margin has narrowed, and it has not distributed any dividends to shareholders. Working capital days have increased, indicating potential liquidity issues. The stock is 4.1% below its 52-week high, and promoter holding remains at 72.30%.
- Where it stands
- Astonea Labs Ltd has shown strong revenue growth, but net profit has remained flat, and the net profit margin has declined. The stock is 4.1% below its 52-week high, and working capital days have increased, raising concerns about liquidity. The company's latest quarter net profit was ₹3 crore.
Summarised by DocStoX's model on 2026-09-09 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.9/10
Weak
Fair Value
Sign in to see
ROE
7.90%
Weak
P/E
71.94x
Expensive
Debt / Equity
0.75
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
52W₹118.00
₹369.00
DocStoX take
Supported by growth (10.0) and momentum (7.5), but held back by valuation (0.0). Growth looks strong at 10.0, but that is offset by valuation at 0.0 and quality at 2.2. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence4.9
/10
Weak
Quality
Weak
ROE 7.9%
Valuation
Expensive
P/E 71.9×
Growth
Strong
Revenue +30.1% 3Y CAGR
Risk
Moderate
D/E 0.75
Momentum
Strong
82% of 52-week range
At a glance
Market Cap
₹340 Cr
52W High / Low
₹369 / ₹118
Dividend Yield
—
Promoter Holding
72.44%
EPS (TTM)
₹4.49
Book Value
₹54.35
Key highlights
- Profit compounding 65% a year
- Revenue compounding 30% a year
- Quality is weak (2.2/10)
- Valuation is weak (0.0/10)
2 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Astonea Labs Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Astonea Labs Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedZydus Lifesciences LimitedApollo Hospitals Enterprise LimitedCipla LimitedDr. Reddy's Laboratories LimitedMankind Pharma LimitedAurobindo Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Astonea Labs Ltd with peers
Related tools & concepts
Value Astonea Labs Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing